Alopecia-Pipeline Review, H1 2015

Alopecia-Pipeline Review, H1 2015

  • Products Id :- GMDHC6154IDB
  • |
  • Pages: 68
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Alopecia-Pipeline Review, H1 2015


Global Markets Direct's, 'Alopecia-Pipeline Review, H1 2015', provides an overview of the Alopecia's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alopecia and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides a snapshot of the global therapeutic landscape of Alopecia

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Alopecia and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Alopecia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Alopecia pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Alopecia

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Alopecia pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Global Markets Direct Report Coverage 7

Alopecia Overview 8

Therapeutics Development 9

Pipeline Products for Alopecia-Overview 9

Pipeline Products for Alopecia-Comparative Analysis 10

Alopecia-Therapeutics under Development by Companies 11

Alopecia-Therapeutics under Investigation by Universities/Institutes 13

Alopecia-Pipeline Products Glance 14

Late Stage Products 14

Clinical Stage Products 15

Early Stage Products 16

Alopecia-Products under Development by Companies 17

Alopecia-Products under Investigation by Universities/Institutes 18

Alopecia-Companies Involved in Therapeutics Development 19

AndroScience Corporation 19

Bristol-Myers Squibb Company 20

C3 Jian, Inc 21

Follicum AB 22

Kuhnil Pharmaceutical Co., Ltd. 23

Lee's Pharmaceutical Holdings Limited 24

Panacea Biotec Limited 25

ProCertus BioPharm Inc. 26

Taisho Pharmaceutical Co., Ltd. 27

Tigo GmbH 28

Vida Therapeutics Inc. 29

Alopecia-Therapeutics Assessment 30

Assessment by Monotherapy Products 30

Assessment by Target 31

Assessment by Mechanism of Action 33

Assessment by Route of Administration 35

Assessment by Molecule Type 37

Drug Profiles 39

abatacept (recombinant)-Drug Profile 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

ASCJ-9-Drug Profile 42

Product Description 42

Mechanism of Action 42

R&D Progress 42

calcitriol-Drug Profile 44

Product Description 44

Mechanism of Action 44

R&D Progress 44

DHL-HisZnNa-Drug Profile 45

Product Description 45

Mechanism of Action 45

R&D Progress 45

interferon beta-1b-Drug Profile 46

Product Description 46

Mechanism of Action 46

R&D Progress 46

KI-1104-Drug Profile 47

Product Description 47

Mechanism of Action 47

R&D Progress 47

KI-1105-Drug Profile 48

Product Description 48

Mechanism of Action 48

R&D Progress 48

Peptide for Alopecia-Drug Profile 49

Product Description 49

Mechanism of Action 49

R&D Progress 49

Peptide for Alopecia and Chemotherapy Effects-Drug Profile 50

Product Description 50

Mechanism of Action 50

R&D Progress 50

ProDermaCel-Drug Profile 52

Product Description 52

Mechanism of Action 52

R&D Progress 52

Recombinant Peptides for Alopecia-Drug Profile 53

Product Description 53

Mechanism of Action 53

R&D Progress 53

Recombinant Proteins to Antagonize IFN-Gamma Receptor for Alopecia Areata and Graft Arteriosclerosis-Drug Profile 54

Product Description 54

Mechanism of Action 54

R&D Progress 54

Small Molecule to Inhibit ALK5 for Alopecia and Fibrosis-Drug Profile 55

Product Description 55

Mechanism of Action 55

R&D Progress 55

Small Molecules to Activate P2Y5 Receptor for Alopecia-Drug Profile 56

Product Description 56

Mechanism of Action 56

R&D Progress 56

Small Molecules to Inhibit Plasminogen Activator Inhibitor-1 for Thromboembolic Disease, PCOS and Alopecia-Drug Profile 57

Product Description 57

Mechanism of Action 57

R&D Progress 57

V-2248-Drug Profile 58

Product Description 58

Mechanism of Action 58

R&D Progress 58

ZK-003-Drug Profile 59

Product Description 59

Mechanism of Action 59

R&D Progress 59

Alopecia-Recent Pipeline Updates 60

Alopecia-Dormant Projects 63

Alopecia-Discontinued Products 65

Alopecia-Product Development Milestones 66

Featured News & Press Releases 66

Jul 23, 2012: Berg Pharma Launches Clinical Trial On BPM 31543 For Prevention Of Chemotherapy-induced Alopecia 66

Appendix 67

Methodology 67

Coverage 67

Secondary Research 67

Primary Research 67

Expert Panel Validation 67

Contact Us 67

Disclaimer 68

List of Tables

Number of Products under Development for Alopecia, H1 2015 9

Number of Products under Development for Alopecia-Comparative Analysis, H1 2015 10

Number of Products under Development by Companies, H1 2015 12

Number of Products under Investigation by Universities/Institutes, H1 2015 13

Comparative Analysis by Late Stage Development, H1 2015 14

Comparative Analysis by Clinical Stage Development, H1 2015 15

Comparative Analysis by Early Stage Development, H1 2015 16

Products under Development by Companies, H1 2015 17

Products under Investigation by Universities/Institutes, H1 2015 18

Alopecia-Pipeline by AndroScience Corporation, H1 2015 19

Alopecia-Pipeline by Bristol-Myers Squibb Company, H1 2015 20

Alopecia-Pipeline by C3 Jian, Inc, H1 2015 21

Alopecia-Pipeline by Follicum AB, H1 2015 22

Alopecia-Pipeline by Kuhnil Pharmaceutical Co., Ltd., H1 2015 23

Alopecia-Pipeline by Lee's Pharmaceutical Holdings Limited, H1 2015 24

Alopecia-Pipeline by Panacea Biotec Limited, H1 2015 25

Alopecia-Pipeline by ProCertus BioPharm Inc., H1 2015 26

Alopecia-Pipeline by Taisho Pharmaceutical Co., Ltd., H1 2015 27

Alopecia-Pipeline by Tigo GmbH, H1 2015 28

Alopecia-Pipeline by Vida Therapeutics Inc., H1 2015 29

Assessment by Monotherapy Products, H1 2015 30

Number of Products by Stage and Target, H1 2015 32

Number of Products by Stage and Mechanism of Action, H1 2015 34

Number of Products by Stage and Route of Administration, H1 2015 36

Number of Products by Stage and Molecule Type, H1 2015 38

Alopecia Therapeutics-Recent Pipeline Updates, H1 2015 60

Alopecia-Dormant Projects, H1 2015 63

Alopecia-Dormant Projects (Contd..1), H1 2015 64

Alopecia-Discontinued Products, H1 2015 65

List of Figures

Number of Products under Development for Alopecia, H1 2015 9

Number of Products under Development for Alopecia-Comparative Analysis, H1 2015 10

Number of Products under Development by Companies, H1 2015 11

Number of Products under Investigation by Universities/Institutes, H1 2015 13

Comparative Analysis by Clinical Stage Development, H1 2015 15

Comparative Analysis by Early Stage Products, H1 2015 16

Assessment by Monotherapy Products, H1 2015 30

Number of Products by Top 10 Targets, H1 2015 31

Number of Products by Stage and Top 10 Targets, H1 2015 32

Number of Products by Top 10 Mechanism of Actions, H1 2015 33

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 34

Number of Products by Top 10 Routes of Administration, H1 2015 35

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 36

Number of Products by Top 10 Molecule Types, H1 2015 37

Number of Products by Stage and Top 10 Molecule Types, H1 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

AndroScience Corporation

Bristol-Myers Squibb Company

C3 Jian, Inc

Follicum AB

Kuhnil Pharmaceutical Co., Ltd.

Lee's Pharmaceutical Holdings Limited

Panacea Biotec Limited

ProCertus BioPharm Inc.

Taisho Pharmaceutical Co., Ltd.

Tigo GmbH

Vida Therapeutics Inc.

Alopecia Therapeutic Products under Development, Key Players in Alopecia Therapeutics, Alopecia Pipeline Overview, Alopecia Pipeline, Alopecia Pipeline Assessment

select a license

Single User License
USD 2000 INR 129780
Site License
USD 4000 INR 259560
Corporate User License
USD 6000 INR 389340



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]